ARTEMIS MEDICARE SERVICES
|
|
BOM : 542919     NSE : ARTEMISMED     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward Pledged Shares : Average [>25% and <50%] |
Feb 18,2025 |
Price(EOD): ₹ 260.30
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Hospital & Healthcare Services |
MCap: ₹ 3,581.73 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
ARTEMIS MEDICARE SERVICES | 0.2% | -15.6% | 47.5% |
APOLLO HOSPITALS ENTERPRISE | 0% | -7.9% | -4.6% |
MAX HEALTHCARE INSTITUTE | 3.4% | -3.7% | 16.9% |
GLOBAL HEALTH | 2.9% | 6.2% | -21.2% |
FORTIS HEALTHCARE | -1.9% | -5.7% | 41.4% |
NARAYANA HRUDAYALAYA | -0.8% | 3.9% | -2.9% |
ASTER DM HEALTHCARE | -6.2% | -18.9% | -13.3% |
DR LAL PATHLABS | -1.6% | -6% | 6.3% |
KRISHNA INSTITUTE OF MEDICAL SCIENCES | -10.2% | -12.2% | 24.6% |
FUNDAMENTAL ANALYSIS OF ARTEMIS MEDICARE SERVICES
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF ARTEMIS MEDICARE SERVICES
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
48.69
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 73.56 Cr
[Latest Qtr - Dec2024 - Consolidated Results ] 8.11
P/B Calculated based on Book Value of Rs 441.84 Cr
[Latest Year - Mar2024 - Consolidated Results ] 3.88
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 922.26 Cr
[Latest Qtr - Dec2024 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
17138% 2575% 269% |
SHARE PRICE MOMENTUM OF ARTEMIS MEDICARE SERVICES
ARTEMIS MEDICARE SERVICES vs SENSEX
DEBT OF ARTEMIS MEDICARE SERVICES
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0.63 0.68 0.6 0.64 |
0.68 0.74 0.64 0.69 |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF ARTEMIS MEDICARE SERVICES
Pledged Promoter Shares |
44.53 % | |
---|---|---|
As on : Dec2024 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF ARTEMIS MEDICARE SERVICES
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-3.74% -11.36% -12.25% -6.93% |
6.22% 14.78% 64.4% 78.32% |
QtrlyTrend |
0 | |
Latest Qtr: Dec2024 | ||
Quarterly Result Analysis → |
ARTEMIS MEDICARE SERVICES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE HEALTHCARE | -1.9% | -6.4% | 14.8% |
S&P BSE ALLCAP | -3.6% | -5.3% | 3.2% |
S&P BSE MIDSMALLCAP | -4.5% | -12.8% | -0.8% |
S&P BSE SMALL CAP | -6.3% | -15.8% | -2.1% |
You may also like the below Video Courses
FAQ about ARTEMIS MEDICARE SERVICES
Is ARTEMIS MEDICARE SERVICES good for long term investment?
As on Feb 18,2025, the Fundamentals of ARTEMIS MEDICARE SERVICES look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of ARTEMIS MEDICARE SERVICES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is ARTEMIS MEDICARE SERVICES UnderValued or OverValued?
As on Feb 18,2025, ARTEMIS MEDICARE SERVICES is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of ARTEMIS MEDICARE SERVICES ?
As on Feb 18,2025, the Intrinsic Value of ARTEMIS MEDICARE SERVICES is Rs. 9.73 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 1.51
Fair Value [Median EV / Sales Model] : Rs. 9.73
Fair Value [Median Price / Sales Model] : Rs. 70.60
Estimated Median Fair Value of ARTEMIS MEDICARE SERVICES : Rs. 9.73
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.